Avinger (AVGR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AVGR Avinger

Watchlist

0.4826
-0.2335-32.61%

Close Dec 20 16:00 ET

0.4829
+0.0003+0.06%

Post 19:59 ET

1.54MMarket Cap-0.06P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Avinger's 2024 Stockholder Meeting and Director Elections
TipRanksDec 19 17:47 ET
Express News | Avinger Has Received A Notice Of Allowance For A U.S. Patent Titled "CATHETER DEVICE WITH DETACHABLE DISTAL END (FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE)"
BenzingaDec 19 16:01 ET
Avinger Executives Waive Rights Amid Liquidation Plans
TipRanksDec 13 16:58 ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
BenzingaDec 12 16:05 ET
Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
BenzingaDec 12 05:41 ET
Avinger Shares Slide 27% on Proposal for Potential Dissolution
WSJDec 11 18:58 ET

Comments

Jaguar8

Yesterday 07:46

🟢 Watchlist FRIDAY December 20,2024. N F A !

NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...

Trytosaveabit

Yesterday 05:06

News

$Avinger (AVGR.US)$ Avinger Has Received A Notice Of Allowance For A U.S. Patent Titled "CATHETER DEVICE WITH DETACHABLE DISTAL END (FOR THE TREATMENT OF PERIPHERAL ARTERY DISEASE)"

NEWS

$Avinger (AVGR.US)$
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
Avinger hosted a webinar featuring key opinion leaders discussing new approaches to treating Peripheral Artery Disease (PAD) Below-the-Knee (BTK). The webinar presented updated data from the IMAGE-BTK study, which evaluated the safety and efficacy of Pantheris SVdevice in BTK procedures. The study enrolled 51 patients with 58 lesions, with follow-up ...